Post-graduate training
Florida International University | Miami, FL
Fellowship in clinical and translational research | Medical University of South Carolina (MUSC)

Scholarly Interests
Dr. Chbib’s primary research goals are directed towards designing and synthesizing new chemical molecules with therapeutic activity. Her research interests are directed towards targeting the quorum sensing process in bacteria.
She has published several original research manuscripts, abstracts and book chapters in the infectious diseases area and presented her research in multiple national organizations like the American Association of Pharmaceutical Sciences (AAPS), American Association of Colleges of Pharmacy (AACP) and others like Cambridge Healthtech Institute.

Dr Chbib’s research received multiple grant fundings and involves optimizing dissolution and quantification techniques of multiple drugs in blood/plasma samples using analytical techniques. She is actively collaborating with the Vaccine Nanotechnology Laboratory and Center for Drug Delivery Research at Mercer University to evaluate the immune potency of new synthetic molecules for the development of new vaccines to prevent different types of infections.
She currently serves as an Editorial board member for Frontiers in Public Health journal and is a Guest Editor for a special issue in Vaccines journal (Vaccines | Special Issue : Novel Adjuvants and Delivery Systems for Vaccines (mdpi.com))

Selected Publications:
• Chbib C, Rashid MA, Shah SM, Kazi M, Uddin MN. Evaluating the Release of Different Commercial Orally Modified Niacin Formulations In Vitro. Polymers (Basel). 2023 Jul 14;15(14):3046. doi: 10.3390/polym15143046. PMID: 37514436; PMCID: PMC10386545.
• Eliazar J, Johnson T, Chbib C. Pre-clinical Impact of the Synergistic Mechanism of Daptomycin and Ceftaroline on Patients with Methicillin-resistant Staphylococcus aureus Bacteremia Infections. Curr Rev Clin Exp Pharmacol. 2021;16(4):296-299. doi: 10.2174/1574884715666210108103813. PMID: 33423652.
• Chbib C, Shah SM, Gala RP, Uddin MN. Potential Applications of Microparticulate-Based Bacterial Outer Membrane Vesicles (OMVs) Vaccine Platform for Sexually Transmitted Diseases (STDs): Gonorrhea, Chlamydia, and Syphilis. Vaccines (Basel). 2021 Oct 27;9(11):1245. doi: 10.3390/vaccines9111245. PMID: 34835176; PMCID: PMC8618863.
• Chbib, C. Impact of the structure-activity relationship of AHL analogues on quorum sensing in Gram-negative bacteria. Bioorg. Med. Chem. 2020;28(3):115282. doi: 10.1016/j.bmc.2019.115282.
• Chbib C. Unexpected furanose-pyranose isomerization of 4-C-alkylfuranose. Carbohydr. Res. 2019;16;487:107879. doi:10.1016/j.carres.2019.107879. PMID:31759322.
• Chbib C, Sobczak AJ, Mugdal M, Gonzales C, Lumpuy, D, Nagaj J, Stokowa-Soltys K, Wnuk SF. S-ribosylhomocysteine analogues modified at the ribosyl C-4 position. J. of Sulfur Chem. 2016;37:307-327.

Certifications
Board Certified Pharmacist (Florida)
Board Certified Consultant Pharmacist
Board Certified Immunizer
Medication Therapy Management (MTM)
Veterinary Pharmacy